Hepatocelluar Carcinoma (HCC) Treatment Response Through Imaging Assessment
Determining the progression and the responses of Hepatocellular Carcinoma (HCC). Professor Andrew X. Zhu, MD, PhD from Harvard Medical School and also the Director of Liver Cancer Research, comes to u...
Author: obr
Added: 01/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Phase 2 ONC201 Neuroendocrine Desmoplastic Small Round Cell Tumor Neuroblastoma Clear-Cell Carcinoma
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the Phase 2 ONC201 Patient Selection and other Neuroendocrine Tumors such as Desmop...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
HCC under the microscope: From bench to bedside
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Bruno Daniele discusses the latest advances in translational medicine for hepatocellular ca...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
New treatment approaches for advanced, unresectable HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Jordi Bruix discusses novel treatment approaches for patients with advanced, unresectable h...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
New developments in locoregional treatments for HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Luigi Bolondi discusses the latest advancements in locoregional therapy for patients with h...
Author: imedex
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Squamous Cell Carcinoma 4+ EGFR Carboplatin Cetuximab Safely or Bevacizumab
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses squamous cell carcinoma 4+ EGFR and giving carboplatin cetuximab safely or bevacizumab. From the 22nd Annual Perspectives in Thoracic Oncology i...
Author: thoraciconcology
Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Squamous Cell Carcinoma Is There Hope?
Paul K. Paik, MD of Memorial Sloan Kettering Cancer Center discusses whether there is hope for squamous cell carcinoma. From the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex'>http://imedex...</a>...
Author: thoraciconcology
Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts
JAMA Dermatology : Fluorouracil for Prevention of Keratinocyte Carcinoma
Interview with Martin A. Weinstock, author of Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 3, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - December 8, 2017 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Treatment of metastatic renal cell carcinoma (mRCC) in the elderly
Neeraj Agarwal, MD Associate Professor of Medicine Director, Genitourinary Oncology Co-leader, Urologic Oncology Multidisciplinary Program Huntsman Cancer Institute, University of Utah discusses the t...
Author: kidneycancer
Added: 11/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 11, 2017 Category: Cancer & Oncology Source Type: podcasts
Renal Medullary Carcinoma
Pavlos Msaouel MD, PhD Chief Fellow, Hematology/Oncology MD Anderson Cancer Center discusses Renal Medullary Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL. <br />
Author: kidneycancer
Added: 11/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 11, 2017 Category: Cancer & Oncology Source Type: podcasts
IMmotion150: Novel Radiological Endpoints and Updated Data From a Randomized Phase II Trial Investigating Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma
Sumanta Kumar Pal, M.D City of Hope Cancer Center discusses IMmotion150: Novel Radiological Endpoints and Updated Data From a Randomized Phase II Trial Investigating Atezolizumab With or Without Bevac...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Comparative GenomicProfilingofMatched Primary and Metastatic Tumors in Renal Cell Carcinoma
Comparative GenomicProfilingofMatched Maria Becerra, MD discusses Primary and Metastatic Tumors in Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL. <br />
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
